GlassScriptPhysician profile
Ronak B Patel
NPI 1760652275
$2,528.70
in general payments reported to CMS, 2019-2025
23 companies · $317 in 2025
The $317 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $139 · 2021: $15.36 · 2022: $15.98 · 2023: $272 · 2024: $1,322 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209 · Travel and Lodging: $702.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.81 |
| Travel and Lodging | $702.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,074.62 | 2024 | Evoque |
| Boston Scientific Corporation | $298.12 | 2019-2025 | Watchman Access System, Watchman Flx |
| Novartis Pharmaceuticals Corporation | $170.50 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $146.92 | 2023-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $110.27 | 2019-2024 | Wainua |
| Janssen Pharmaceuticals, INC | $105.45 | 2019-2023 | Xarelto |
| Medtronic, INC. | $92.08 | 2024 | Corevalve Evolut R |
| Kestra Medical Technology Services, INC. | $81.18 | 2023 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.82 | 2019-2025 | Lifevest |
| Pfizer INC. | $65.31 | 2019-2025 | |
| Atricure, INC. | $46.52 | 2024 | |
| Merck Sharp & Dohme LLC | $32.43 | 2025 | Zerbaxa, Recarbrio |
| Abiomed | $31.72 | 2025 | |
| Daiichi Sankyo INC. | $27.67 | 2019-2023 | Injectafer |
| Shockwave Medical, INC | $27.30 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $23.94 | 2025 | Xt Cdx |
| Philips North America LLC | $22.33 | 2025 | Extended Holter |
| Esperion Therapeutics, INC. | $18.48 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $18.21 | 2025 | Neffy |
| Sanofi-Aventis U.S. LLC | $17.29 | 2019 | |
| Amgen INC. | $15.36 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $14.78 | 2025 | Opsynvi, Uptravi |
| Regeneron Healthcare Solutions, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronak Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.